0.1100CAD-4.35%Mkt Cap: 5.99M CADP/E: —Last update: 2026-06-01
Innovotech Inc. provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap5.99M CAD
Enterprise Value5.15M CAD
Revenue (TTM)4.02M CAD
Gross Profit2.40M CAD
Net Income (TTM)94.38K CAD
Revenue/Share0.0740 CAD
Last Price0.1100 CAD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees—
CountryCA
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-19.15
EV/Revenue1.28
P/S1.56
P/B1.74
EPS (TTM)-0.01
EPS (Forward)—
52W Range
0.11000% of range0.3400
52W High0.3400 CAD
52W Low0.1100 CAD
Profitability
Gross Margin52.86%
Oper. Margin-59.27%
EBITDA Margin-6.69%
Profit Margin2.08%
ROE2.62%
ROA2.13%
Growth
Revenue Growth-44.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-62.35K CAD
CapEx (TTM)471.52K CAD
FCF Margin-20.42%
FCF Yield-13.72%
Net Debt-1.16M CAD
Net Debt/EBITDA4.29
Balance Sheet
Debt/Equity0.04
Current Ratio3.28
Quick Ratio2.76
Book Value/Sh0.0660 CAD
Cash/Share0.0240 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.54.44M
Float31.45M
Insiders41.38%
Institutions0.00%
Short Interest
Short Ratio0.0d
Short % Out.0.00%
Shares Short46
Short (prev mo.)372
Technical
SMA 500.1718 (-36.0%)
SMA 2000.2193 (-49.8%)
Beta1.27
S&P 52W Chg27.70%
Avg Vol (30d)54.45K
Avg Vol (10d)49.27K
Technical Indicators
RSI (14)24.6
MACD-0.0214
MACD Signal-0.0173
MACD Hist.-0.0041
BB Upper0.2472 CAD
BB Middle0.1603 CAD
BB Lower0.0733 CAD
BB Width108.54%
ATR (14)0.0082 CAD
Vol Ratio (20d)0.29x